Search results for #gastroenteropancreatic
#FDA approves #lutetium Lu 177 dotatate for pediatric patients 12 years and older with #gastroenteropancreatic #neuroendocrine #tumors #GEP-#NETS (followed by Marc #Lacroix, #Wallonia) fda.gov/drugs/resource…
#FDA has approved #Novartis' #radioligand therapy #Lutathera® for #pediatric patients with #gastroenteropancreatic #neuroendocrine #tumors (GEP-NETs). This marks the first therapy specifically approved for children with these rare #tumors. #cancer healthandpharma.net/fda-approve-no…
.@RadioMedixand and @OranoMed receive #FDA Breakthrough Therapy Designation for #AlphaMedixTM in #gastroenteropancreatic #neuroendocrine tumors - ow.ly/3wG850QAaRX #rarediseases #orphandrugs
#Novartis Reports Significant Reduction in Disease Progression or #Death with #Lutathera as First-Line Treatment for Advanced #Gastroenteropancreatic Neuroendocrine #Tumors ipharmacenter.com/post/american-… #GI24 #ASCO #News #Media #BREAKING #pharma #pharmaceutical #healthcare #conference
NETTER-2 trial, led by #Novartis, demonstrated that #Lutathera plus #octreotide significantly reduces disease progression or death by 72% in advanced #gastroenteropancreatic #neuroendocrine #tumors (#GEPNETs). healthandpharma.net/novartis-lutat…
📌Circulating Angiogenic Markers in #Gastroenteropancreatic #Neuroendocrine #Neoplasms: A #SystematicReview by 👥Dr. Irina Sandra et al. 🏦“Carol Davila” University of Medicine and Pharmacy 🔓mdpi.com/1467-3045/44/9…
RT @SocSurgOnc From @AnnSurgOncol: Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis. #gastroenteropancreatic #neuroendocrineneoplasms rdcu.be/c3zhU @McMastersKelly x.com/annsurgoncol/s…
RT @SocSurgOnc From @AnnSurgOncol: Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis. #gastroenteropancreatic #neuroendocrineneoplasms rdcu.be/c3zhU @McMastersKelly x.com/annsurgoncol/s…
From @AnnSurgOncol: Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis. #gastroenteropancreatic #neuroendocrineneoplasms rdcu.be/c3zhU @McMastersKelly
From @AnnSurgOncol: Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis. #gastroenteropancreatic #neuroendocrineneoplasms rdcu.be/c3zhU @McMastersKelly
DECEMBER ISSUE: Surgical Management of G3 #gastroenteropancreaticNeuroendocrineNeoplasms: A Systematic Review and Meta-analysis. #gastroenteropancreatic #neuroendocrineneoplasms rdcu.be/c3zhU @McMastersKelly @SocSurgOnc
A validated risk-score model using age, LVI , and tumor location, grade, and size can calculate the risk of #lymphonodemetastases in #gastroenteropancreatic #neuroendocrinetumors patients, a new @pennsurgery @ABShannonMD study published in @acsJACS. journals.lww.com/journalacs/ful…
Read 'Comparative Outcomes of Second-line Topoisomerase-I Inhibitor Therapies on Neuroendocrine Carcinoma' from #JournalofGastrointestinalCancer for free using #SharedIt: rdcu.be/cEQa6 #Neuroendocrinecarcinoma #Neuroendocrinetumors #Gastroenteropancreatic
#Lutathera from #Novartis is indicated to treat #Somatostatin receptor-positive #Gastroenteropancreatic neuroendocrine #Tumors, which include foregut, midgut and handout #NeuroendocrineTumors in adults. drugdiscoverytrends.com/lutathera-supp… @MoffittNews @Novartis #Cancer #Neuro #Novartis
Lanreotide and Keytruda - the PLANET study (NCT03043664) - Ronny Allan - Living with #neuroendocrinecancer @RonnyAllan1 #patientadvocate #cancerawareness #gastroenteropancreatic #neuroendocrine
#Gastroenteropancreatic #neuroendocrine neoplasms (GEP-NETs): don't miss key recommendations for diagnosis, treatment, & follow-up provided in these ESMO Clinical Practice Guidelines 👉 ow.ly/b99u50CP9Jr
#mdpidiagnostics The Challenge of Evaluating Response to Peptide #Receptor #Radionuclide #Therapy in #Gastroenteropancreatic #NeuroendocrineTumors: The Present and the Future @UZH_en 🙌mdpi.com/2075-4418/10/1…
Comprehensive genomic profiling of #gastroenteropancreatic #neuroendocrine neoplasms. clincancerres.aacrjournals.org/content/early/…
Individualizing care for #gastroenteropancreatic #neuroendocrine #tumours Clinical Spotlight: 1.The #epidemiology & #pathophysiology of GEP-NETs 2.The difficulties in diagnosing GEP-NETs 3.Current & future #biomarkers for #diagnosis & #treatment Watch: bit.ly/3j94CAV
